Skip to main content
Brain logoLink to Brain
. 2018 Mar 8;141(4):e34. doi: 10.1093/brain/awy063

Corrigendum

PMCID: PMC6790503  PMID: 29528374

Ortal Barel, May Christine V. Malicdan, Bruria Ben-Zeev, Judith Kandel, Hadass Pri-Chen, Joshi Stephen, Inês G. Castro, Jeremy Metz, Osama Atawa, Sharon Moshkovitz, Esther Ganelin, Iris Barshack, Sylvie Polak-Charcon, Dvora Nass, Dina Marek-Yagel, Ninette Amariglio, Nechama Shalva, Thierry Vilboux, Carlos Ferreira, Ben Pode-Shakked, Gali Heimer, Chen Hoffmann, Tal Yardeni, Andreea Nissenkorn, Camila Avivi, Eran Eyal, Nitzan Kol, Efrat Glick Saar, Douglas C. Wallace, William A. Gahl, Gideon Rechavi, Michael Schrader, David M. Eckmann, Yair Anikster. Deleterious variants in TRAK1 disrupt mitochondrial movement and cause fatal encephalopathy. Brain 2017; 140: 568–81; 10.1093/brain/awx002.

The authors apologize for an error in the author affiliations, which should read as follows:

Ortal Barel,1,2,* May Christine V. Malicdan,3,4,* Bruria Ben-Zeev,2,5,6,* Judith Kandel,7,† Hadass Pri-Chen,3,5 Joshi Stephen,3 Inês G. Castro,8 Jeremy Metz,8 Osama Atawa,9 Sharon Moshkovitz,1,2 Esther Ganelin,5,6 Iris Barshack,5,10 Sylvie Polak-Charcon,5,10 Dvora Nass,5,10 Dina Marek-Yagel,2,5,11 Ninette Amariglio,1,2 Nechama Shalva,5,11 Thierry Vilboux,3,12 Carlos Ferreira,3,13 Ben Pode-Shakked,5,11,14 Gali Heimer,5,6,14 Chen Hoffmann,5,15 Tal Yardeni,16 Andreea Nissenkorn,5,17 Camila Avivi,10 Eran Eyal,1,2 Nitzan Kol,1,2 Efrat Glick Saar,1,2 Douglas C. Wallace,16 William A. Gahl,3,4 Gideon Rechavi,1,2,5 Michael Schrader,8 David M. Eckmann7,18,19 and Yair Anikster2,5,11

*These authors contributed equally to this work.

1 Sheba Cancer Research Center, Sheba Medical Center, Tel-Hashomer, Israel

2 The Wohl Institute for Translational Medicine, Sheba Medical Center, Tel-Hashomer, Israel

3 Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA

4 NIH Undiagnosed Diseases Program, NHGRI, National Institutes of Health, Bethesda, Maryland, USA

5 Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel

6 Pediatric Neurology Unit, Edmond and Lily Safra Children’s Hospital, Sheba Medical Center, Tel-Hashomer, Israel

7 Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania, USA

8 Department of Biosciences, College of Life and Environmental Sciences, University of Exeter, Exeter, UK

9 Palestenian Red Crescent Society Hospital, Department of Pediatrics, Hebron City, Palestine

10 Department of Pathology, Sheba Medical Center, Tel-Hashomer, Israel

11 Metabolic Disease Unit, Edmond and Lily Safra Children’s Hospital, Sheba Medical Center, Tel-Hashomer, Israel

12 Inova Translational Medicine Institute, Inova Health System, Falls Church, Virginia, USA

13 Division of Genetics and Metabolism, Children’s National Health System, Washington DC, USA

14 The Dr. Pinchas Borenstein Talpiot Medical Leadership Program, Sheba Medical Center, Tel-Hashomer, Israel

15 Department of Radiology, Sheba Medical Center, Tel-Hashomer, Israel

16 Center for Mitochondrial and Epigenomic Medicine, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA

17 Service for Rare Disorders, Pediatric Neurology Unit, Edmond and Lily Safra Children’s Hospital, Sheba Medical Center, Tel-Hashomer, Israel

18 Department of Anesthesiology and Critical Care, Perelman School of Medicine, Philadelphia, Pennsylvania, USA

19 Institute for Medicine and Engineering, University of Pennsylvania, Philadelphia, Pennsylvania, USA

Present address: Complete Healthcare Communications, Inc, One Dickinson Drive Chadds Ford, PA, USA


Articles from Brain are provided here courtesy of Oxford University Press

RESOURCES